PI
ABOS icon

PFG Investments’s Acumen Pharmaceuticals ABOS Stock Holding History

PFG Investments’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$191K Buy
80,850
+61,850
+326% +$158K 0.01% 1073
2025
Q4 		$40.1K Buy
19,000
+7,500
+65% +$14.9K ﹤0.01% 1124
2025
Q3 		$19.7K Buy
+11,500
New +$15.9K ﹤0.01% 1105

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

PFG Investments's ABOS Position: Q1 2026 in Review

PFG Investments increased its Acumen Pharmaceuticals (ABOS) stake by 326% in Q1 2026, buying an estimated $158K and bringing the position to 80,850 shares worth $191K. The position accounts for 0.01% of the portfolio, ranked #1073.

PFG Investments first reported a position in ABOS in Q3 2025 and has held it in 3 quarters since. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • PFG Investments held 80,850 shares of Acumen Pharmaceuticals worth $191K as of Q1 2026.
  • PFG Investments bought 61,850 Acumen Pharmaceuticals shares in Q1 2026, an estimated $158K.
  • Acumen Pharmaceuticals made up 0.01% of PFG Investments's portfolio in Q1 2026, its #1073 holding.
  • PFG Investments first reported a position in Acumen Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.